Arcus Biosciences, Inc. (RCUS)
NYSE: RCUS · Real-Time Price · USD
23.35
-0.90 (-3.71%)
Apr 20, 2026, 10:12 AM EDT - Market open
Arcus Biosciences Market Cap
Arcus Biosciences has a market cap or net worth of $2.93 billion as of April 20, 2026. Its market cap has increased by 250.49% in one year.
Market Cap
2.93B
Enterprise Value
2.25B
1-Year Change
250.49%
Ranking
Category
Stock Price
$23.35
Market Cap Chart
Since March 15, 2018, Arcus Biosciences's market cap has increased from $708.10M to $2.93B, an increase of 313.35%. That is a compound annual growth rate of 19.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 3.04B | 18.14% |
| Dec 31, 2025 | 2.57B | 88.83% |
| Dec 31, 2024 | 1.36B | -4.69% |
| Dec 29, 2023 | 1.43B | -4.52% |
| Dec 30, 2022 | 1.50B | -47.33% |
| Dec 31, 2021 | 2.84B | 68.68% |
| Dec 31, 2020 | 1.69B | 263.86% |
| Dec 31, 2019 | 463.20M | -3.26% |
| Dec 31, 2018 | 478.80M | -32.38% |
| Mar 15, 2018 | 708.10M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Catalyst Pharmaceuticals | 3.21B |
| Alumis | 3.18B |
| Beam Therapeutics | 3.12B |
| Arcutis Biotherapeutics | 3.04B |
| Vera Therapeutics | 3.03B |
| Relay Therapeutics | 3.00B |
| IDEAYA Biosciences | 2.98B |
| Enliven Therapeutics | 2.88B |